We are live on
!
Find out more
YMRC
Yorktown Management & Research Company Portfolio holdings
AUM
$163M
1-Year Est. Return
68.53%
This Fund
S&P 500
This Quarter
Est. Return
+28.06%
1 Year Est. Return
+68.53%
3 Year Est. Return
+222.75%
5 Year Est. Return
+299.09%
10 Year Est. Return
+935.04%
AUM
$112M
AUM Growth
+$12.7M
(+13%)
Cap. Flow
-$8.66M
Cap. Flow
% of AUM
-7.76%
Top 10 Holdings %
Top 10 Hldgs %
19.8%
Holding
340
New
104
Increased
18
Reduced
43
Closed
87
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$5.02M |
| 2 |
Franklin Resources
BEN
|
+$572K |
| 3 |
Etsy
ETSY
|
+$540K |
| 4 |
Crown Holdings
CCK
|
+$503K |
| 5 |
BERY
Berry Global Group, Inc.
BERY
|
+$497K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Encompass Health
EHC
|
+$828K |
| 2 |
Lam Research
LRCX
|
+$792K |
| 3 |
PetMed Express
PETS
|
+$791K |
| 4 |
Becton Dickinson
BDX
|
+$781K |
| 5 |
First Hawaiian
FHB
|
+$772K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.34% |
| 2 | Healthcare | 13.43% |
| 3 | Consumer Discretionary | 12.59% |
| 4 | Financials | 10.09% |
| 5 | Industrials | 10% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Stryker
SYK
$133B
| $306K | 0.27% |
+1,700
| New | +$314K |
|
177
Cognex
CGNX
$10.2B
| $305K | 0.27% |
+5,100
| New | +$277K |
|
178
Globus Medical
GMED
$11.5B
| $305K | 0.27% |
6,400
| – | – |
|
179
Global Payments
GPN
$23.4B
| $305K | 0.27% |
1,800
| – | – |
|
180
L3Harris
LHX
$54.1B
| $305K | 0.27% |
+1,800
| New | +$338K |
|
181
Neurocrine Biosciences
NBIX
$15.9B
| $305K | 0.27% |
+2,500
| New | +$276K |
|
182
CBRE Group
CBRE
$42.7B
| $303K | 0.27% |
+6,700
| New | +$289K |
|
183
Medtronic
MDT
$116B
| $303K | 0.27% |
+3,300
| New | +$316K |
|
184
TTEC Holdings
TTEC
$77.4M
| $303K | 0.27% |
6,500
| – | – |
|
185
KKR & Co
KKR
$99.5B
| $300K | 0.27% |
9,700
| – | – |
|
|
RP
186
DELISTED
RealPage, Inc.
RP
| $299K | 0.27% |
+4,600
| New | +$290K |
|
187
Alphabet (Google) Class A
GOOGL
$4.2T
| $298K | 0.27% |
4,200
| – | – |
|
188
Phillips 66
PSX
$90B
| $298K | 0.27% |
4,150
-2,150
| -34% | -$152K |
|
|
CONE
189
DELISTED
CyrusOne Inc Common Stock
CONE
| $298K | 0.27% |
+4,100
| New | +$292K |
|
190
Constellation Brands
STZ
$22.9B
| $297K | 0.27% |
1,700
| – | – |
|
|
JNCE
191
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $297K | 0.27% |
+43,000
| New | +$232K |
|
192
Applied Materials
AMAT
$435B
| $296K | 0.27% |
4,900
-4,100
| -46% | -$221K |
|
193
Factset
FDS
$9.89B
| $296K | 0.27% |
900
| – | – |
|
194
Newmont
NEM
$124B
| $296K | 0.27% |
+4,800
| New | +$284K |
|
195
Raymond James Financial
RJF
$34.9B
| $296K | 0.27% |
+6,450
| New | +$291K |
|
196
Meta Platforms (Facebook)
META
$1.47T
| $295K | 0.26% |
1,300
| – | – |
|
197
CME Group
CME
$94.3B
| $293K | 0.26% |
1,800
+500
| +38% | +$89.6K |
|
198
KLA
KLAC
$272B
| $292K | 0.26% |
15,000
-17,000
| -53% | -$291K |
|
199
Insulet
PODD
$10.1B
| $291K | 0.26% |
1,500
| – | – |
|
|
CTLT
200
DELISTED
CATALENT, INC.
CTLT
| $290K | 0.26% |
+3,950
| New | +$268K |
|
Similar funds
OFM
TCGDR
PCR
IVGAI
CC
PWAM
CWR
CWMGO
Yorktown Management & Research Company's Q2 2020 Portfolio in Review
As of Q2 2020, Yorktown Management & Research Company held 340 positions worth $112M, up 13% from $98.9M the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Yorktown Management & Research Company withdrew a net $8.66M in Q2 2020, closing 87 positions and reducing 43 holdings. Its most notable exit was Lam Research, an estimated $792K position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Yorktown Management & Research Company opened a new position in iShares MBS ETF worth $5.01M.
- Yorktown Management & Research Company's largest Q2 2020 buy was iShares MBS ETF: 45,300 shares worth $5.01M.
- Yorktown Management & Research Company added most to TD Ameritrade Holding Corp in Q2 2020, an estimated $354K increase.
- Yorktown Management & Research Company's biggest Q2 2020 reduction was Encompass Health, cutting an estimated $828K.
- Yorktown Management & Research Company fully exited Lam Research in Q2 2020, selling an estimated $792K.
- Yorktown Management & Research Company's ten largest holdings make up 20% of its $112M portfolio in Q2 2020.
- Yorktown Management & Research Company opened 104 new positions and closed 87 in Q2 2020.
- Yorktown Management & Research Company's portfolio value rose 13% quarter-over-quarter to $112M.
Based on Yorktown Management & Research Company's 13F filing for Q2 2020, filed 11 Aug 2020.